lamivudine
information and resources from the National Cancer Institute
lamivudine
A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP). In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA. In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. lamivudine
A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP). In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA. In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase.
|
|
|
|
news articles
FDA Approves Drug Regimen To Treat AIDS 01 Apr 2006
All Headline News The regimen consists of lamivudine/zidovudine fixed dose combination tablets and efavirenz tablets. They are used to combat HIV-1 infection in adults. ...
MNP+, INP+ oppose patent for ARV drug 01 Apr 2006
KanglaOnline, ...by GlaxoSmithKline (GSK) for Combivir, an anti-retroviral drug that is a fixed-dose combination of two essential AIDS drugs zidovudine/lamivudine (AZT/3TC). ...
Novartis says China telbivudine data confirms drug's superiority ... Mar 26, 2006
Forbes Novartis AG said new clinical data from China shows the superiority of hepatitis B treatment telbivudine after one year of use over commonly used lamivudine. ...
Lamivudine in order to prevent hepatitis B relapse during ... Mar 14, 2006
Xagena.it, The idea of preemptively treating these patients with the antiviral drug Lamivudine ( Epivir ) in order to prevent hepatitis B relapse and it varying ...
Entecavir versus Lamivudine for Patients with HBeAg-Negative ... Mar 8, 2006
New England Journal of Medicine (subscription), ...negative chronic hepatitis B who had not previously been treated with a nucleoside analogue to receive 0.5 mg of entecavir or 100 mg of lamivudine once daily ...
New Data Shows Telbivudine Provided Significantly Greater Response ... Mar 27, 2006
DG News ...and clinical efficacy in Chinese patients with chronic hepatitis B (CHB) after 1-year of treatment when compared with a current standard of care, lamivudine. ...
NGO opposes GSK’s bid for AIDS drug Mar 30, 2006
Economic Times, ...patent application of multinational pharma major GlaxoSmithKline for Combivir, a fixed dose combination of two essential AIDS drugs--Zidovudine and Lamivudine. ...
Baraclude (Entecavir) Demonstrated Benefits Over Lamivudine In ... Mar 9, 2006
DG News 9, 2006 -- Baraclude™ (entecavir) demonstrated greater benefit in treating nucleoside-naïve chronic hepatitis B patients compared to lamivudine, the most ...
Entecavir Demonstrates Benefits Over Lamivudine In Hepatitis B ... Mar 9, 2006
EndoNurse, NJ -- BARACLUDE™ (entecavir) demonstrated greater benefit in treating nucleoside-naive chronic hepatitis B patients compared to lamivudine, the most commonly ...
New data show telbivudine superior to lamivudine in treatment of ... Mar 27, 2006
WebWire (press release), ...superior antiviral and clinical efficacy in Chinese patients with this disease after one year of use when compared with the commonly used treatment lamivudine. ...
Idenix (IDIX) and Novartis Said Telbivudine More Effective Than ... Mar 27, 2006
StreetInsider.com (subscription), Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) and Novartis (NYSE: NVS) announced new data that demonstrate telbivudine ... StreetInsider ...
The NEJM Reports BARACLUDE™ (entecavir) Demonstrated Benefits ... Mar 10, 2006
Medical News Today (press release), BARACLUDE™ (entecavir) demonstrated greater benefit in treating nucleoside-naïve chronic hepatitis B patients compared to lamivudine, the most commonly used ...
Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic ... Mar 8, 2006
New England Journal of Medicine (subscription), ...positive chronic hepatitis B who had not previously received a nucleoside analogue to receive either 0.5 mg of entecavir or 100 mg of lamivudine once daily for ...
Medivir: Medivir's Antiviral MIV-210 (FLG) Inhibits Hepatitis B ... Mar 28, 2006
Finanzen.net, ...and hiscolleagues at INSERM in Lyon, France that Medivir's antiviral MIV-210(FLG) in laboratory assays is active against lamivudine- andadefovir-resistant HBV. ...
Medivir: Medivir's Antiviral MIV-210 (FLG) Inhibits Hepatitis B ... Mar 28, 2006
Business Wire (press release), Zoulim and his colleagues at INSERM in Lyon, France that Medivir's antiviral MIV-210 (FLG) in laboratory assays is active against lamivudine- and adefovir ...
(PRN) - Metabasis Therapeutics Announces Pricing of Common Stock ... Mar 27, 2006
Bolsamania.com, ...(PRN) - New Data Shows Telbivudine Provided Significantly Greater Response Compared to Lamivudine in the Treatment of Chinese Patients with Chronic Hepatitis B ...
The New England Journal of Medicine Reports BARACLUDE(TM) ... Mar 8, 2006
Yahoo! News (press release) FirstCall/ -- BARACLUDE(TM) (entecavir) demonstrated greater benefit in treating nucleoside-naive chronic hepatitis B patients compared to lamivudine, the most ...
Initial Antiretroviral Treatment of HIV Infection Mar 10, 2006
eMaxHealth.com, ...of the virus, with fewer problems of anemia, fatigue and nausea than another widely used combination of antiretrovirals, zidovudine and lamivudine (AZT and 3TC ...
Newer Hepatitis B Drug Bests Standard Treatment Mar 8, 2006
Forbes ...on hepatitis B, researchers from around the world have found the medication entecavir is more effective than the commonly used drug lamivudine in managing the ...
PowderMed’s therapeutic DNA vaccine for chronic hepatitis B ... Mar 30, 2006
Innovations-Report, ...by PMED™, PowderMed’s needle-free delivery technology, in patients with chronic hepatitis B infection, both in combination with lamivudine and as ...
Rare resistance mutation, K65N, means that multiple NRTIs don't ... Mar 26, 2006
Aidsmap, ...therapy consisting of the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (Sustiva), abacavir (Ziagen) and 3TC (lamivudine, Epivir). ...
PowderMed's Therapeutic DNA Vaccine for Chronic Hepatitis B Enters ... Mar 29, 2006
Business Wire (press release), ...by PMED(TM), PowderMed's needle-free delivery technology, in patients with chronic Hepatitis B infection, both in combination with lamivudine and as monotherapy ...
New Antiretroviral Strategies for First-Line and "Switch" Patients ... Mar 22, 2006
Medscape (subscription) ...is a double-blinded, placebo-controlled trial that compares the safety and efficacy of abacavir or nevirapine with fixed dose zidovudine/lamivudine in therapy ...
Idenix Announces Thirteen Data Presentations at the 2006 European ... Mar 17, 2006
PR Newswire (press release), Lamivudine in HBeAg-Positive Patients with Chronic Hepatitis B: Efficacy, Safety, and Predictors of Response at 1 Year" in the poster session beginning on ...
Aurobindo receives first NDA approval for HIV-1 drug from US FDA Mar 16, 2006
domain-B, Aurobindo Pharma Ltd has announced having received the first new drug approval (NDA) from US FDA for Lamivudine 150mg / Zidovudine 300mg for fixed-dose ...
Aurobindo gets 1st NDA approval for ARV product Mar 16, 2006
India Infoline.com, Aurobindo Pharma Ltd on Thursday announced that the Company has received the first New Drug Approval (NDA) from US FDA for Lamivudine 150 mg/Zidovudine 300 mg ...
Study: Newer hepatitis B drug is more effective Mar 10, 2006
The Advocate, ...of Medicine show that Bristol-Myers Squibb's new drug Baraclude (entecavir) is more effective against hepatitis B than GlaxoSmithKline's Epivir (lamivudine). ...
Aurobindo gets NDA approval from USFDA Mar 15, 2006
Hindustan Times, Aurobindo Pharma Ltd said on Thursday that it has received the first New Drug Approval (NDA) from USFDA for Lamivudine 150 mg, Zidovudine 300 mg fixed-dose ...
Novartis files telbivudine in China for Hep B Mar 26, 2006
Reuters ...the treatment of patients with chronic hepatitis B for approval in China after data showed it was superior to the commonly used treatment lamivudine in Chinese ...
Encysive Pharma Shares Plummet Mar 27, 2006
BusinessWeek ...significantly greater antiviral and clinical efficacy in Chinese patients with chronic hepatitis B after one year of treatment when compared with lamivudine. ...
Idenix Pharmaceuticals Inc. Is Heading Higher On Study Results Mar 27, 2006
Trading Markets, ...antiviral and clinical efficacy in Chinese patients with chronic hepatitis B after 1-year of treatment, compared with a current standard of care, lamivudine. ...
(PRN) - Cingular Wireless Investing More Than $90 Million in Its ... Mar 27, 2006
Bolsamania.com, ...[+]. (PRN) - New Data Shows Telbivudine Provided Significantly Greater Response Compared to Lamivudine in the Treatment of Chinese Patients with Chronic ...
Newer hepatitis drug more effective - studies Mar 8, 2006
Reuters.uk, Among the patients who were treated with Epivir, known generically as lamivudine, only 62 percent of the 314 patients improved in the same time. ...
Drug promotion Mar 27, 2006
Shanghai Daily, ...yesterday that telbivudine, a new drug for chronic hepatitis B, has better antiviral and clinical efficacy in Chinese patients than lamivudine, the commonly ...
Baraclude Trumps Epivir as HBV Therapy Mar 8, 2006
MedPage Today, March 8 - In patients with hepatitis B infections, two international studies showed that Baraclude (entecavir) beat out Epivir (lamivudine) at improving ...
US FDA Grants Traditional Approval for Gilead's Once-Daily HIV ... Mar 8, 2006
DG News Study 934, a phase 3 open-label trial comparing a once-daily regimen of Viread, Emtriva and efavirenz to twice-daily Combivir® (lamivudine/zidovudine) and once ...
US FDA Grants Traditional Approval for Gilead's Once-Daily HIV ... Mar 8, 2006
International News Service, Study 934, a Phase III open-label trial comparing a once-daily regimen of Viread, Emtriva and efavirenz to twice-daily Combivir(R) (lamivudine/zidovudine) and ...
Aurobindo gets NDA approval from USFDA Mar 15, 2006
Hindu, Mumbai, March 16. (PTI) Aurobindo Pharma Ltd today said it has received the first New Drug Approval (NDA) from USFDA for Lamivudine 150 mg, Zidovudine 300 mg ...
BMS hepatitis B drug shines in phase 3 Mar 8, 2006
United Press International WASHINGTON, March 8 (UPI) -- The New England Journal of Medicine said Wednesday that BMS's Baraclude is better than lamivudine for hepatitis B. ...
CROI: early vs delayed Trizivir in TB/HIV coinfected - no ... Mar 2, 2006
Aidsmap, Starting antiretroviral treatment with Trizivir (abacavir, zidovudine and lamivudine fixed dose combination) almost immediately after beginning TB treatment ...
Healthcare: At a Glance - Roche Hepatitis Drug Thrust Onto Front ... Mar 3, 2006
International News Service, GlaxoSmithKline's Epivir (lamivudine) is the best-known product in this disease area, although Schering-Plough's Intron A (interferon alfa-2b) is also used to ...
Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR ... Mar 9, 2006
Aidsmap, The US Food and Drug Administration this week granted tentative approval for a copackaged antiretroviral drug regimen, consisting of lamivudine/zidovudine (AZT ...
FDA List Serve - Tentative approval of copackaged antiviral regim ... Mar 9, 2006
PharmaLive.com (press release), Drug Administration (FDA) on March 6, 2006, granted tentative approval for a copackaged antiretroviral drug regimen, consisting of lamivudine/zidovudine fixed ...
BMS Hepatitis B Drug Shines in Phase 3 Mar 8, 2006
International News Service, The New England Journal of Medicine said Wednesday that BMS's Baraclude is better than lamivudine for hepatitis B. Bristol-Myers ...
Aurobindo to sell BMS' anti-AIDS drugs Mar 17, 2006
Reuters India, ...the US Food and Drug Administration had given a tentative approval to its version of an anti-AIDS combination drug consisting of Lamivudine, Zidovudine and ...
Nigerian Firm To Produce One Million AIDS Drugs Daily Mar 16, 2006
Nigeria Daily Independent, Archivir, the new drug, is a triple combination of Stavudine, Lamivudine and Nevirapine, which hitherto formed different regimens. ...
Study finds no link between brain-penetrating antiretroviral drugs ... Mar 21, 2006
Aidsmap, Previous studies have shown that these are AZT (zidovudine, Retrovir), d4T (stavudine, Zerit), 3TC (lamivudine, Epivir), abacavir (Ziagen), nevirapine (Viramune ...
Report alerts of resistance to AIDS drugs in Nigeria Mar 22, 2006
AngolaPress, ...of Medical Research in Lagos, Oni Idigbe, put the levels of resistance recorded with the three drugs used in the country (Nevirapine, Lamivudine and Stavudine ...
Aurobindo gets nod for FDC anti-AIDS drug Mar 9, 2006
Economic Times, ...has received tentative approval from the US Food and Drugs Administration for fixed dose combination (FDC) of anti-HIV/AIDS drugs lamivudine, zidovudine and ...
HAART failure rate halves in seven years Mar 24, 2006
Aidsmap, 46% in 2002). The most common nucleoside backbone remained AZT (zidovudine, Retrovir) and lamivudine (3TC, Epivir) throughout the study period. ...
Epivir®-HBV Reduces Risk of Liver Inflammation During ... Mar 16, 2006
Cancer Consultants (press release), ...hepatitis (inflammation of the liver) during chemotherapy for lymphoma if they received preventive treatment with the anti-viral agent Epivir®-HBV (lamivudine ...
No aid for city AIDS patients in war over life-saving drugs Mar 3, 2006
Kolkata Newsline, ART includes a combination of drugs like Efavirenz, Nevirapine, Zadivudine, Lamivudine and Stafudine, which is initiated on critical AIDS patients with the CD ...
FDA Grants Aurobindo Approval for Antiretroviral Therapy Mar 16, 2006
Kaiser network.org, The approval is for lamivudine 150 mg and zidovudine 300 mg fixed dose tablets packaged with efavirenz 600 mg tablets ( Dow Jones , 3/16). ...
Traditional Approval of Viread and Truvada Mar 13, 2006
PharmaLive.com (press release), ...the recently submitted Study 934, which compared the antiviral activity of tenofovir DF, emtricitabine, and efavirenz to zidovudine, lamivudine and efavirenz ...
AUDIO SUMMARY Mar 8, 2006
New England Journal of Medicine (subscription), Featured are articles on entecavir and lamivudine for HBeAg-positive and HBeAg-negative chronic hepatitis B, thalidomide and hematopoietic-cell transplantation ...
Filed for Approval Mar 9, 2006
R&D Directions (subscription), The study is an ongoing two-year Phase III clinical trial comparing telbivudine with a standard therapy, lamivudine, in 1,367 adults with chronic hepatitis B ...
Aurobindo's another drug gets place in WHO's pre-qualification ... Dec 20, 2005
India Infoline.com, The other products included are Zidovudine tablets mg, Lamivudine tablets-150 mg & Lamivudine tablets-300 mg. This is one more milestone for the Company. ...
Novel Drug Pradefovir Mesylate May Emerge as Treatment Option in ... Dec 15, 2005
DG News ...mesylate P450 (PDV), might become a viable treatment option for patients with hepatitis B (HBV) who are resistant to standard treatment with lamivudine. ...
More HIV/AIDS Drugs Approved Dec 15, 2005
Hardbeatnews.com, They are Efavirenz, 600 mg tablets; Lamivudine, a 10mg/ml Oral solution; Lamivudine/zidovudine, 150/300 mg tablets; Lamivudine/zidovudine + nevirapine, 150/300 ...
Aurobindo’s Nevirapine included in WHO list Dec 11, 2005
Sify, The other products included are Zidovudine tablets - 300 mg, Lamivudine tablets - 150 mg and Lamivudine tablets - 300 mg, it said. ...
Aurobindo’s Nevirapine included in WHO list Dec 12, 2005
Andhra Cafe, This is the company's fourth product to be included in the list along with others tablets Zidovudine tablets - 300 mg, Lamivudine tablets - 150 mg and ...
Aurobindo Pharma`s product included in WHO pre-qualification list Dec 12, 2005
Myiris.com, ...list. The other products included are Zidovudine tablets - 300 mg, Lamivudine tablets - 150 mg & Lamivudine tablets - 300 mg. Nevirapine ...
Aurobindo Pharma's anti-AIDS drug selected by WHO Dec 12, 2005
domain-B, The others are 300mg-Zidovudine tablets, and the 150mg- and 300mg-Lamivudine tablets. Nevirapine is a key anti-retroviral (ARV), in the treatment of AIDS. ...
Long-Term Adefovir Dipivoxil Effective for HIV and Treatment ... Nov 21, 2005
DG News SAN FRANCISCO, CA -- November 21, 2005 – Long-term use of adefovir dipivoxil (Hepsera) as an add-on to lamivudine appears effective in hard-to-treat ...
European Medicines Agency gives first positive opinions on ... Nov 20, 2005
Medical News Today (press release), The first products undergoing the new procedure are Lamivudine GSK 150 mg film-coated tablets and Lamivudine/Zidovudine GSK film-coated tablets, from Glaxo ...
Switching from twice-daily Combivir to once-daily Truvada in ... Nov 23, 2005
Xagena.it, Data suggest that in HIV-infected treatment-experienced patients who switched from twice-daily Combivir ( Lamivudine 150 mg/Zidovudine 300 mg ) to once-daily ...
Number of Pills Affects Adherence to HIV Treatment Regimens Nov 30, 2005
PR Newswire (press release), ...on Time * HIV positive patients taking COMBIVIR achieved a >/= 95 percent adherence rate more than twice as often as patients taking lamivudine and zidovudine ...
Ranbaxy to launch HIV drug combo in India Nov 30, 2005
United Press International Virolis-E contains two fixed dose combination tablets of Lamivudine and Stavudine and one tablet of Efavirenz. Virocomb-E consists ...
Committee for Medicinal Products for Human Use Summary of Opinion ... Nov 18, 2005
PharmaLive.com (press release), 2005 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive scientific opinion for the medicinal product Lamivudine/zidovudine GSK film ...
NEW DRUGS FOR HEPATITIS B Dec 14, 2005
Charlotte Sun-Herald, There are five drugs now available for it -- interferon, peginterferon, lamivudine, entecavir and adefovir. Sometimes a combination of these drugs is used. ...
Ranbaxy Launches Two New Anti-Hiv Products In India On World Aids ... Dec 6, 2005
Medical News Today (press release), It is a compliance pack containing two fixed dose combination tablets of Lamivudine 150mg & Stavudine 30/40mg and one tablet of Efavirenz 600mg. ...
Tenofovir More Effective than Adefovir for Long-Term Treatment of ... Nov 23, 2005
DG News Viread) appears to be more effective and less affected by resistance mutations than adefovir for long term use in patients with lamivudine resistant hepatitis B ...
Number of Pills Affects Adherence to HIV Treatment Regimens Nov 30, 2005
PharmaLive.com (press release), Patients taking a fixed-dose combination of lamivudine (3TC) 150 mg and zidovudine (ZDV) 300 mg (COMBIVIR(R)) achieved >/= 95 percent adherence more than twice ...
Cheaper drugs brighten AIDS scene Nov 30, 2005
Daily News & Analysis, The cost of a common three-drug Antiretroviral Therapy (ART) regimen (Zidovudine, Lamivudine, Nevirapine) is about Rs 1300-1500 per month. ...
Pfizer releases further details of liver toxicity in maraviroc ... Dec 5, 2005
Aidsmap, ...study screening period, the patient first began receiving study drugs that included maraviroc 300 mg once daily (blinded study drug) and zidovudine/lamivudine. ...
AIDS - the real pandemic Nov 30, 2005
Sydney Morning Herald (subscription), Zhang and many others are urging Neverapine to be replaced by Lamivudine, which produces milder side effects, but Beijing's efforts to obtain cheap supplies ...
Govt medicine spending slammed as 'pathetic' Dec 5, 2005
Stuff.co.nz, ...candesartan), breast cancer (letrozole), nausea from cancer treatments (hyoscine, ondansetron, tropisetron), hepatitis B and C (lamivudine, pegylated interferon ...
Govt ’must uphold high ARV standards’ Dec 9, 2005
IPP Media - Guardian, The Arusha-based Tanzania Pharmaceuticals Industries Limited (TPI) will manufacture the TT-VIR, which is a combination of Nivirapine, Lamivudine and Stavudine ...
Kivexa available on PBS Dec 7, 2005
NAPWA, Kivexa, a new single-pill combination of the antiviral drugs abacavir (Ziagen) and lamivudine (3TC) became available for S100 prescription from 1 December. ...
Premature to say atazanavir not linked to fat loss, says ... Dec 12, 2005
Aidsmap, Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naïve HIV ...
Neurological side-effects of efavirenz mild and transient, study ... Dec 12, 2005
Aidsmap, ...efavirenz plus abacavir. All three arms also took AZT (zidovudine, Retrovir) and 3TC (lamivudine, Epivir). “Transient, subjective ...
Ranbaxy announces new co-packaged triple ART combinations Dec 2, 2005
Aidsmap, Virolis-E is a `compliance pack` containing two fixed dose combination tablets of lamivudine (3TC) 150mg and stavudine (d4T) 30/40mg and one tablet of ...
New Data Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen ... Nov 18, 2005
Yahoo! News (press release) ...the randomized, uncontrolled, open-label, prospective Phase II study of 100 treatment-naive patients taking Kaletra in combination with lamivudine (3TC) and ...
*vwd/BUSINESS WIRE: 24-Wochen-Daten zur Wirkung von HIV-Patienten ... Nov 17, 2005
Vereinigte Wirtschaftsdienste, Data suggest that in HIV-infected treatment-experienced patients who switched from twice-daily Combivir(R) (lamivudine 150 mg/zidovudine 300 mg) to once-daily ...
HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A ... Nov 18, 2005
MedIndia, The currently available drugs are Zidovudine, Stavudine, Lamivudine, Abacavir, Indinavir, Efavirenz, Nevirapine and Didanosine. ...
WHO adds two HIV/AIDS medicines to prequalified list Dec 1, 2005
Xinhua, The HIV/AIDS medicines are the antiretrovirals nevirapine, produced by Aurobindo, India, and lamivudine, produced by Aspen Pharmacare Ltd, South Africa. ...
The overuse of Tamiflu in treating avian flu Dec 2, 2005
Jakarta Post, From a list of antivirals, only acyclovir, lamivudine, ribavirin, and interferon (pegylated included) have reached clinically satisfactory results. ...
WHO puts Aspen, Aurobindo drugs on AIDS list Dec 1, 2005
Reuters India, Aspen -- the first African producer to be included on the WHO's list of prequalified medicines -- had its lamivudine, produced in 150 mg tablets, added to the ...
Aspen gets on WHO Aids ARV list Dec 1, 2005
Business Day, ...of enhancing access to these products, understanding that the first line treatment at this point in time consists of the three drugs Lamivudine, Stavudine and ...
Tenofovir doesn't harm growth of kids' bones, suggests small study Nov 28, 2005
Aidsmap, All switched from a stable antiretroviral treatment regimen consisting of 3TC (lamivudine, Epivir), d4T (stavudine, Zerit) and a protease inhibitor to a ...
AIDS research: Now, NARI test patients to get free medicines Nov 23, 2005
Pune Newsline, ...by the end of 2005 on a structured ART programme according to which a fixed dose combination of drugs supplied by WHO (stavudine, lamivudine and nevaripine) is ...
Aurobindo Pharma's AIDS drug added to WHO list Dec 1, 2005
India Infoline.com, WHO inducted Lamivudine 150 mg tablets, from Aspen, the first African producer to be included on the WHO's list of pre-qualified medicines. ...
New drug gives patients hope Nov 17, 2005
China Daily, ...an oral anti-viral drug, has shown the new treatment to be more effective at suppressing hepatitis B virus than the current standard anti-viral drug, lamivudine ...
Abbott HIV drug zaps viral loads in trial Nov 18, 2005
United Press International Specifically, data from the study of 100 treatment-naive patients taking Kaletra in combination with lamivudine and stavudine showed that 59 percent of ...
|
|
